CH EPL (R5)
1.0.0-ci-build - ci-build Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Dataexport FOPH Spezialitätenliste
... 4 Abrilada
... 5 Cuprior
... 6 Entocort
... 7 Estalis
... 8 Keytruda
... 9 Paxlovid
... 10 Triogen
... 11 Profiles
... 12 Extensions
... 13 Terminology
... 14 Changelog
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Full Limitation Text
.... 15.15 CH - EPL Product Price
.... 15.16 CH - EPL Regulated Authorization Limitation
.... 15.17 CH - EPL Reimbursement SL
.... 15.18 CH - SMC Authorized Dose Form
.... 15.19 CH - Authorisation Type
.... 15.20 CH - Medicinal Product Name Type
.... 15.21 CH - Other Characteristics Type
.... 15.22 CH EPL - Gamme
.... 15.23 CH EPL - Limitation Status
.... 15.24 CH EPL - Listing Status
.... 15.25 CH EPL - Other Characteristics Packaged Item
.... 15.26 CH EPL - Price Type
.... 15.27 CH EPL - Product Type
.... 15.28 CH EPL - Reimbursement Status
.... 15.29 CH EPL - Type of Price Change
.... 15.30 CH SMC - Additional Monitoring Indicator
.... 15.31 CH SMC - Attached Document Type
.... 15.32 CH SMC - Authorisation Category
.... 15.33 CH SMC - Authorisation Status
.... 15.34 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.35 CH SMC - Ingredient Role
.... 15.36 CH SMC - Legal Status of Supply
.... 15.37 CH SMC - Marketing Status
.... 15.38 CH SMC - Pediatric Use Indicator
.... 15.39 CH SMC - Special Precautions for Storage
.... 15.40 CH SMC - Substance
.... 15.41 CH SMC - TherapeuticProductcode
.... 15.42 EDQM - Combination Packaging
.... 15.43 EDQM - Combined Pharmaceutical Dose Form
.... 15.44 EDQM - Combined Term
.... 15.45 EDQM - Packaging
.... 15.46 EDQM - Pharmaceutical Dose Form
.... 15.47 EDQM - Route Of Administration
.... 15.48 EDQM - Unit of Presentation
.... 15.49 EMA - Domain
.... 15.50 EMA - Intended Effect
.... 15.51 EMA - Shelf Life Type
.... 15.52 CH - Authorisation Type
.... 15.53 CH - Medicinal Product Name Type
.... 15.54 CH - Other Characteristics Type
.... 15.55 CH EPL - Gamme
.... 15.56 CH EPL - Limitation Status
.... 15.57 CH EPL - Listing Status
.... 15.58 CH EPL - Other Characteristics Packaged Item
.... 15.59 CH EPL - Price Type
.... 15.60 CH EPL - Product Type
.... 15.61 CH EPL - Reimbursement Status
.... 15.62 CH EPL - Type of Price Change
.... 15.63 CH SMC - Additional Monitoring Indicator
.... 15.64 CH SMC - Attached Document Type
.... 15.65 CH SMC - Authorisation Category
.... 15.66 CH SMC - Authorisation Status
.... 15.67 CH SMC - Ingredient Role
.... 15.68 CH SMC - Legal Status of Supply
.... 15.69 CH SMC - Marketing Status
.... 15.70 CH SMC - Pediatric Use Indicator
.... 15.71 CH SMC - Special Precautions for Storage
.... 15.72 CH SMC - Substance
.... 15.73 CH SMC - TherapeuticProductcode
.... 15.74 EDQM - Standard Terms
.... 15.75 EMA - Domain
.... 15.76 EMA - Intended Effect
.... 15.77 EMA - Shelf Life Type
.... 15.78 FOPH Dossier Number
.... 15.79 GLN Identifier
.... 15.80 Global Trade Item Number
.... 15.81 LOC Identifier
.... 15.82 5204201
.... 15.83 52042011
.... 15.84 5470402
.... 15.85 54704089
.... 15.86 66231001
.... 15.87 6623101
.... 15.88 67431001
.... 15.89 6743101
.... 15.90 67719001
.... 15.91 6771901
.... 15.92 67831001
.... 15.93 67831001
.... 15.94 6783101
.... 15.95 68793001
.... 15.96 6879301
.... 15.97 ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle)
.... 15.98 Abrilada, Injektionslösung
.... 15.99 Abrilada, Injektionslösung Fachinformation
.... 15.100 Abrilada, Injektionslösung Fachinformation
.... 15.101 CH-52042011
.... 15.102 CH-54704089
.... 15.103 CH-66231001
.... 15.104 CH-67431001
.... 15.105 CH-67831001
.... 15.106 CH-67831002
.... 15.107 CH-68291001
.... 15.108 CH-68793001
.... 15.109 CUPRIOR Filmtabl 150 mg (Bundle)
.... 15.110 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.111 Cuprior, Filmtabletten Fachinformation
.... 15.112 Cuprior, Filmtabletten Patienteninformation
.... 15.113 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.114 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.115 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.116 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.117 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.118 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.119 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.120 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.121 Indication 10002556
.... 15.122 Indication 10003268
.... 15.123 Indication 10009900
.... 15.124 Indication 10019927
.... 15.125 Indication 10020041
.... 15.126 Indication 10021782
.... 15.127 Indication 10027400
.... 15.128 Indication 10028881
.... 15.129 Indication 10030247
.... 15.130 Indication 10031285
.... 15.131 Indication 10037153
.... 15.132 Indication 10037160
.... 15.133 Indication 10043971
.... 15.134 Indication 10045365
.... 15.135 Indication 10046851
.... 15.136 Indication 10061091
.... 15.137 Indication 10075566
.... 15.138 Indication 10084529
.... 15.139 Indication 10089182
.... 15.140 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.141 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.142 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.143 Limitation 156370009
.... 15.144 Limitation 254837009
.... 15.145 Limitation 34000006
.... 15.146 Limitation 59393003
.... 15.147 Limitation 64766004
.... 15.148 Limitation 69896004
.... 15.149 Limitation 79886009
.... 15.150 Limitation 840539006
.... 15.151 Limitation 9014002
.... 15.152 Limitation 9631008
.... 15.153 MI Abrilada-40mg-Pre-Filled-Pen
.... 15.154 MI Budesonidum-2.3mg-Tablet
.... 15.155 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.156 MI Nirmatrelvir-150mg-Tablet
.... 15.157 MI Pembrolizumab-100mg-Vial
.... 15.158 MI Ritonavirum-100mg-Tablet
.... 15.159 MI Solvent
.... 15.160 MI Trientinum-150mg-Tablet
.... 15.161 MI Trientinum-250mg-Capsule
.... 15.162 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.163 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.164 Paxlovid, Filmtabletten Patienteninformation
.... 15.165 PhP Abrilada-40mg-Pre-Filled-Pen
.... 15.166 PhP Budesonidum-Suspension
.... 15.167 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.168 PhP Pembrolizumab-100mg-Vial
.... 15.169 PhP Trientinum-150mg-Tablet
.... 15.170 PhP Trientinum-150mg-Tablet
.... 15.171 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.172 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.173 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.174 Reimbursement SL 17418
.... 15.175 Reimbursement SL 17973
.... 15.176 Reimbursement SL 20416
.... 15.177 Reimbursement SL 21070
.... 15.178 Reimbursement SL 21203 1 Pre-Filled Pen
.... 15.179 Reimbursement SL 21203 2 Pre-Filled Pen
.... 15.180 Reimbursement SL 21208
.... 15.181 Reimbursement SL 21529
.... 15.182 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.183 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.184 Triogen, Kapseln Fachinformation
.... 15.185 Triogen, Kapseln Patienteninformation